Seasonal changes in patients with allergic rhinitis with or without asthma Source: Eur Respir J 2003; 22: Suppl. 45, 136s Year: 2003
Evaluation of asthma patients using the control of allergic rhinitis and asthma test (CARAT) Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012
Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007
Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Cost-of-illness study of patients with allergic asthma and seasonal allergic rhinitis in Germany Source: Eur Respir J 2001; 18: Suppl. 33, 399s Year: 2001
Effect of allergic rhinitis on asthma-related hospitalization, GP visit and drug cost among adult asthmatic patients in the UK Source: Eur Respir J 2002; 20: Suppl. 38, 396s Year: 2002
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018
Frequency of bronchial asthma (BA) symptoms, allergic rhinitis and allergic dermatitis among pregnants of Saint-Petersburg Source: Annual Congress 2008 - Asthma epidemiology Year: 2008
Improvements in asthma control and quality of life with omalizumab in allergic (IgE-mediated) asthma patients Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
Allergic asthma: determinants of asthma control Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008
Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study Source: Eur Respir J 2003; 21: 116-122 Year: 2003
Association of asthma control with allergic rhinitis severity in adult patients Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019
Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma at a single UK hospital Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Treatment and outcomes in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
Age at asthma diagnosis in subjects with and without allergic rhinitis. Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors Year: 2018
Efficacy of Loratidin + Pseudoefedrin sulfat in school children with seasonal allergic rhinitis and mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 134s Year: 2003
Control of allergic rhinitis and asthma test, asthma control test and FeNO in asthma Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012